Operator
Good afternoon, ladies and gentlemen, and welcome to the Dicerna Pharmaceuticals First Quarter 2021 Earnings Conference Call. As a reminder, this conference call is being recorded at the company s request.
I will now turn the call over to your host, Will Grammig of Stern IR. Please go ahead.
Lauren Stival
Investor Relations
Thank you, operator. Good afternoon, everyone, and thank you for joining us to review Dicerna s first quarter 2021 financial results and operational highlights. For anyone who hasn t yet had a chance to review our results we issued a press release after the close of trading today, which is available under the investors and media tab on our website at dicerna.com.
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Dicerna Pharmaceuticals Full year 2020 Earnings Conference Call. As a reminder, this conference is being recorded at the company s request. I will now turn the call over to your host, Ms. Lauren Stival, Senior Director of Investor Relations at Dicerna. Please go ahead.
Lauren Stival
Senior Director of Investor Relations
Thank you, operator. Good afternoon, everyone, and thank you for joining us to review Dicerna s full year 2020 financial results and operational highlights. For anyone who hasn t yet had a chance to review our results, we issued a press release after the close of trading today, which is available under the investors and media tab on our website at dicerna.com. You may also listen to this conference call via webcast on our website, which will be archived beginning approximately two hours after the call is completed. Speaking on today s call will be Dicerna s President and CEO, Doug Famb